MENU

Using 3D in vitro tumoroids for personalized medicine

Speaker
  • Deputy Director of the Division of Surgery and Interventional Science, Head of the Department of Surgical Biotechnology, Professor of Cancer Nanotechnology, University College London (UCL)
    BIOGRAPHY

Abstract
Tissue samples can vary in extracellular matrix (ECM) composition, cell heterogeneity, and rigidity. Consequently, dissociation approaches require extensive optimization and care, as improperly disaggregated samples can reduce cell viability, decrease the efficiency of cell compartmentalization and block downstream instrumentation. The isolation process involves tissue dissection, mechanical dissociation, and enzymatic breakdown of the ECM. There is a clear need for tissue dissociation systems for researchers to standardize the digestion and disaggregation of solid tissues samples to consistently obtain high quality, viable cells.
 
Prof. Marilena Loizidou will share the results of an eight-month study into the dissociation of renal cell carcinoma (RCC) tissues from patients for whole genome sequencing and epigenetic research applications. The cells will be used to manufacture and grow tumoroids, 3D in vitro cultures of cancer which mimic the composition and architecture of solid tumors, which will then be cultured and treated with drugs and personalized medicine. Marilena’s approach will be compared to non RCC control and current methods of dissociation.
 
In this webinar you will:
  • Compare approaches to tissue dissociation for optimizing cells for whole genome sequencing
  • Discuss the manufacture and development of tumoroids for use in cancer research and monitoring
  • Review the results of genetic and epigenetic studies comparing the dissociation of renal cell carcinoma (RCC) tissues for use in the manufacture and growth of tumoroids.

Show Resources
You May Also Like
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
JAN 21, 2021 8:00 AM PST
JAN 21, 2021 8:00 AM PST
Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
JUN 24, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources
Attendees
  • See more